Medrysone

甲羟松

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMedrysone
Drug Alias Namemedrisona甲朵酮羟孕酮medrysonum甲羟孕酮 +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsHypersensitivity
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1969/11/28
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesAllergan Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAllergan Plc
Active IndicationsN/A
Inactive IndicationsHypersensitivity

Other Information

ATC CodeS01BA08
Related LinksWikipediaDrugBankKEGG